Security key
161133103
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 14,001
- Total 13F value
- $24,007
- Share change
- 0
- SEC-reported price per share
- $4.36
- Number of holders
- 2
Report period
Q1 2026
Institutions
2
Top holders
2
CHRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Coherus Oncology, Inc. SEC filings
Coherus Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 161133103
Recent filing periods:
Ownership snapshot
Top reported holders of CHRS - CHARMING SHOPPES - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Timothy G. Youngquist 202...
Disclosed value leader
Timothy G. Youngquist 202...
Comparable rows
4/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 8.3%
11 rows are not safely comparable across share classes.
13D/G row: Timothy G. Youngquist 2020 Irrevocable Trust
Showing 1-6 of 15 holder rows.
Quick read
Timothy G. Youngquist 2020 Irrevocable Trust leads the comparable SEC ownership view at 8.3%.
4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Timothy G. Youngquist 2020 Irrevocable Trust's linked filing trail.
Comparable ownership
Top 4
Timothy G. Youngquist 2020 Irrevo...
8.3%
Bering Partners II, L.P.
6.5%
Thomas A. Satterfield Jr.
4.6%
Rubric Capital Management LP
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust |
13D/G
13F
Company
|
8.3%
Reported 13D/G
· 31 Mar 2026
|
$21,803,868
12,750,800 shares
|
-$68,400 | 31 Mar 2026 |
| Bering Partners II, L.P. |
13D/G
Evgeny Zaytsev ("Zaytsev")
|
6.5%
Reported 13D/G
· 05 Sep 2025
|
$12,468,441
7,602,708 shares
|
$0 | 05 Sep 2025 |
| Thomas A. Satterfield Jr. |
13D/G
|
4.6%
Reported 13D/G
· 31 Mar 2026
|
$11,711,700
6,930,000 shares
|
+$1,555,621 | 31 Mar 2026 |
| Rubric Capital Management LP |
13D/G
|
4.6%
Reported 13D/G
· 31 Dec 2024
|
$5,258,754
5,258,754 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$14,999,046
10,562,709 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$14,241,029
10,028,893 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
14,001
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q1 2026 holders
2
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend